about
Burden of Gastrointestinal and Liver Diseases in Middle East and North Africa: Results of Global Burden of Diseases Study from 1990 to 2010Epidemiology and pathophysiology of alcohol and breast cancer: Update 2012Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice ModelEffect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studiesThe cirrhosis epidemic in the UK: evaluating the causes in a European context.Diagnoses of, and deaths from, severe liver disease due to hepatitis C in England between 2000 and 2005 estimated using multiple data sources.Hepatitis and liver disease knowledge and preventive practices among health workers in Mexico: a cross-sectional study.Occupation and renal cell cancer in Central and Eastern EuropeAlcoholic liver disease-related mortality in the United States: 1980-2003.Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis.Recent insights on risk factors of hepatocellular carcinomaChronic administration of ethanol leads to an increased incidence of hepatocellular adenoma by promoting H-ras-mutated cells.Trends in the leading causes of death in Korea, 1983-2012HBV and HCV therapy.Th2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammation.Recognizing and preventing death from compensated cirrhosis in the communityInequalities in Alcohol-Related Mortality in 17 European Countries: A Retrospective Analysis of Mortality RegistersLiver cirrhosis mortality, alcohol consumption and tobacco consumption over a 62 year period in a high alcohol consumption country: a trend analysisRisk of liver cancer among US male veterans with cirrhosis, 1969-1996Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathwaySystematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver diseaseTrends, patterns, and determinants of regional mortality in Belarus, 1990-2007.Alcohol consumption, folate intake, hepatocellular carcinoma, and liver disease mortalityACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in MiceInhibition of SIRT2 suppresses hepatic fibrosis.Trends in the management and burden of alcoholic liver disease.Patient knowledge about disease self-management in cirrhosis.Overview of the PROVE studies evaluating the use of telaprevir in chronic hepatitis C genotype 1 patients.Manganese accumulation in the CNS and associated pathologies.Emerging roles for biomaterials in the treatment of liver disease.Where next for hepatitis B and C surveillance?Liver cirrhosis in England-an observational study: are we measuring its burden occurrence correctly?Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention.Factors affecting mortality and resource use for hospitalized patients with cirrhosis: A population-based studyThe present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3.Mortality from cirrhosis and hepatocellular carcinoma in Western Europe over the last 40 years.The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.Impact of etiological treatment on prognosis.Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975.Factors associated with medication adherence in patients living with cirrhosis.
P2860
Q27000368-33A8777D-18E9-4ED3-AE0F-F1998B7218ECQ28263109-7E5C8B10-433F-4162-8EE7-480573C38507Q28551990-330E1594-A577-44E8-8F38-B8E9EE080E86Q28748551-6F9DC012-E4C3-4A6D-A04F-8B38B552FAA6Q30373848-C084BB09-937B-47C3-ABAB-D53560892F58Q33369992-066F8249-82C2-46E8-A0B7-6673B49C6E9DQ33579221-97AEAC08-D700-4E0F-B6E5-279DAF6CDFFCQ33887239-15C344B4-B6BF-4021-ADD1-E521EA2CD789Q34047667-9766CA9C-F4F5-4372-8487-F166F2CB36ACQ34216210-AD02BFB7-79AD-4DE7-A2CC-97D89E5802BFQ34391482-946F04DC-6BD5-4393-8428-2A135AF3359CQ34561947-CEC94D45-902D-43F9-A361-181839B7AD08Q34591875-10B104B3-15A8-4506-8EF5-DF94BF4C1154Q35259824-44CDF9B8-9896-4E92-8DFD-F006B088AABAQ35565153-5C1C2E55-6772-4EF3-87A3-79A44B55C3EAQ35612709-50F29F18-9275-49DE-9C51-ADDEF3AB6607Q35857293-6E85866E-8E78-4245-A8F4-4C830E918C9FQ35879083-C272D41B-2680-4D1B-A1FE-B6CB43A19AC2Q36075198-79E28E68-62FB-4E8E-AB52-16DC69405A70Q36361268-45754DED-6164-4283-B377-3E0D6936CBA7Q36643026-845003DE-9883-48DB-BCD4-E6766C4B1AF1Q36663907-09B0EEAB-8914-40EF-8A54-81E738B24898Q36681132-95C30AB5-2015-4B36-965F-614A21E80736Q36757066-CE0402D3-5DF0-47EA-9BEE-F18123EFB467Q37071786-D121F331-9F52-45EB-B7B3-4BB52D1BC938Q37237035-5A8DAE68-E119-4B87-A823-88CA14CB4233Q37284454-57381FEB-74FF-45E1-9F84-3FE3602BE453Q37818336-1D10B912-344A-4B76-AD2B-EC5CC1163D64Q37870770-0B72C75E-2D17-419C-A01B-92BB8422F3B8Q37992205-4340CF06-B6BB-4C7D-8FCC-31C17D1B1890Q38371216-DAC0C1DD-E0CA-430B-9567-4209E5C87E9CQ38678212-F33A37C2-0A25-41E8-BCFF-B126B4DAD25FQ38879747-1617CD8C-6BAF-4A66-81BF-4BFA23B660C8Q38939283-6EC352EA-3842-49DB-AF9C-ECA2EC7801B9Q38948615-D336630C-A994-4C11-866B-9ABCC8158765Q39006162-836964E5-D4AD-4707-B86A-1E271F702BDCQ39064153-B3ACC4E5-F770-4643-904E-41EAD1DD5A5EQ39431994-D63C6FAD-D627-4A5D-A55A-F5830814AB55Q39924415-7C952DC1-B005-402D-B180-35D84E9E12D8Q40106356-23FA69A6-3B5E-49DA-93FB-E78F3F88464F
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Worldwide mortality from cirrhosis: an update to 2002.
@en
type
label
Worldwide mortality from cirrhosis: an update to 2002.
@en
prefLabel
Worldwide mortality from cirrhosis: an update to 2002.
@en
P2093
P1476
Worldwide mortality from cirrhosis: an update to 2002.
@en
P2093
Cristina Bosetti
Fabio Levi
Franca Lucchini
Witold A Zatonski
P304
P356
10.1016/J.JHEP.2007.01.025
P577
2007-02-16T00:00:00Z